Related Experiment Video
Updated: Oct 28, 2025

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia
Guangrong Dai1, Lili Pei2, Fenyu Duan1
1Department of Anesthesiology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, China.
Background:
Remimazolam is a new ultrashort acting benzodiazepine anesthetic which has predictable sedative duration and rapid recovery in gastrointestinal endoscopy. Propofol is a commonly used intravenous anesthetic in clinical work which also has rapid action, short action time and rapid recovery. To date, there have been relatively few articles comparing the two for general anesthesia induction. So, we conducted a randomized trial to evaluate whether remimazolam is superior to propofol during anesthesia induction in terms of efficacy and safety.
Methods:
One hundred and eighty nine ASA I or II patients scheduled for elective surgery were divided into four groups: remimazolam 0.2 mg/kg (R1 group), 0.3 mg/kg (R2 group), 0.4 mg/kg (R3 group), and propofol group (P group). All patients were anesthetized with single shots of experimental drugs during induction period. Efficacy was measured by completing the induction of anesthesia without rescue sedation; and safety was defined as no severe adverse events.
Results:
Success induction rates in remimazolam groups were 89% (R1 group), 94% (R2 group) and 100% (R3 group) while success induction rate in P group was 100%. Hypotension rates during induction were lower in R1 group (13%) and R2 group (24%) compared with P group (44%). Hypotension rate in R3 group (34%) was similar to propofol (44%). Injection site pain in group P was 27% while no pain was observed in remimazolam groups.
Conclusions:
Remimazolam is a safe and effective sedative drug during induction with less adverse effects for general anesthesia in ASA I or II patients.
Insights
Remimazolam offers a safe and effective alternative for general anesthesia induction, demonstrating comparable efficacy to propofol with fewer adverse events like injection site pain.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Remimazolam is an ultrashort-acting benzodiazepine anesthetic.
- Propofol is a widely used intravenous anesthetic.
- Limited comparative data exists for anesthesia induction.
Purpose of the Study:
- To evaluate remimazolam's superiority over propofol for general anesthesia induction.
- To compare efficacy and safety profiles of remimazolam and propofol.
Main Methods:
- A randomized trial involving 189 ASA I/II patients.
- Four groups: remimazolam (0.2, 0.3, 0.4 mg/kg) and propofol.
- Efficacy measured by successful induction without rescue sedation; safety by absence of severe adverse events.
Main Results:
- Remimazolam groups showed high success rates (89-100%) comparable to propofol (100%).
- Lower hypotension rates observed with lower remimazolam doses (R1: 13%, R2: 24%) versus propofol (44%).
- No injection site pain reported with remimazolam, unlike propofol (27%).
Conclusions:
- Remimazolam is a safe and effective option for anesthesia induction in ASA I/II patients.
- Remimazolam demonstrates a favorable safety profile with reduced adverse effects compared to propofol.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
06:40An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
Published on: June 8, 2021
Related Concept Videos
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Inhalational Anesthetics: Overview
Stages of General Anesthesia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...